Review Article · Übersichtsarbeit
St. Gallen 2011: Summary of the Consensus DiscussionGnant M.a · Harbeck N.b · Thomssen C.c
a Comprehensive Cancer Center MUW/AKH, Universitätsklinik für Chirurgie, Medizinische Universität Wien, Austria b Brustzentrum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Köln, c Klinik und Poliklinik für Gynäkologie, Martin-Luther-Universität Halle-Wittenberg, Halle/Saale, Germany
Univ. Prof. Dr. Michael Gnant, Comprehensive Cancer Center MUW/AKH, Medizinische Universität Wien – Universitätsklinik für Chirurgie, Währinger Gürtel 18–20, 1090 Wien, Austria, Tel. +43 1 40400-5646, Fax -7603, email@example.com
Do you have an account?
The 2011 St. Gallen Consensus Conference on early breast cancer provided mostly evidence-based treatment recommendations with a broad spectrum of acceptable clinical practice for global breast cancer care. This report summarizes the results of the 2011 international panel voting procedures with regard to locoregional and endocrine treatment, chemotherapy, targeted therapy as well as adjuvant bisphosphonate use.
© 2011 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.